A 32-year-old woman presents with a 3-day history of fever, headache, and mild neck stiffness. She denies photophobia. On examination, temperature is 38.2°C, neck stiffness is mild, and Kernig sign is negative. Fundoscopy is normal. Non-contrast CT head is normal. Lumbar puncture shows: WBC 180/μL (90% lymphocytes), protein 65 mg/dL, glucose 48 mg/dL (serum glucose 110 mg/dL), Gram stain negative, culture negative. PCR for enterovirus is positive. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has **viral meningitis** (most likely **enteroviral meningitis**) confirmed by: - **CSF profile**: Lymphocytic pleocytosis (90% lymphocytes), elevated protein (65 mg/dL), **low glucose (48 mg/dL with serum glucose 110 mg/dL)** — CSF:serum glucose ratio = 0.44 (abnormal). - **Gram stain and culture negative** — rules out bacterial meningitis. - **PCR for enterovirus positive** — confirms viral etiology. ## Key Point: **Enteroviral meningitis is self-limited and does NOT require antiviral therapy.** Once bacterial meningitis is excluded by negative Gram stain and culture, and viral etiology is confirmed (PCR), empirical antibiotics and acyclovir should be discontinued. Management is purely supportive. ## Distinguishing Bacterial vs. Viral Meningitis | Feature | Bacterial | Viral (Enteroviral) | |---------|-----------|--------------------| | **CSF WBC differential** | Neutrophilic (>80% PMN) | Lymphocytic (>80% lymphocytes) | | **CSF protein** | Very high (>200 mg/dL) | Mildly elevated (50–100 mg/dL) | | **CSF glucose** | Very low (<40 mg/dL, ratio <0.4) | Normal to low (ratio 0.4–0.6) | | **Gram stain** | Often positive | Negative | | **Culture** | Positive in 70–80% | Negative | | **PCR** | N/A | Positive for enterovirus, HSV, VZV | | **Antibiotic response** | Rapid improvement | No response to antibiotics | | **Mortality** | 15–25% untreated | <1% | | **Treatment** | Antibiotics (ceftriaxone + vancomycin) | Supportive care only | ## High-Yield: **Enteroviral meningitis is benign and self-limited (3–7 days).** Antibiotics and acyclovir do NOT shorten duration or improve outcomes. Continuing them after viral diagnosis is confirmed is unnecessary and increases antibiotic resistance risk. ## Clinical Pearl: The **low CSF glucose (0.44 ratio)** in this case might initially raise concern for bacterial meningitis, but the **lymphocytic predominance, negative Gram stain, and positive enterovirus PCR** confirm viral etiology. Enteroviral meningitis can occasionally present with low CSF glucose (up to 30% of cases), which is a known variant. ## Mnemonic: **"ELVES" — Enteroviral meningitis is self-limited, Lymphocytic CSF, Viral PCR positive, Empirical antibiotics stopped, Supportive care only.** ## Management Algorithm ```mermaid flowchart TD A["Meningitis: fever + headache<br/>+ neck stiffness"]:::outcome --> B["Perform LP<br/>CSF analysis"]:::action B --> C{"Gram stain<br/>& culture?"}:::decision C -->|"Positive or<br/>high suspicion<br/>for bacteria"| D["Bacterial meningitis<br/>Continue ceftriaxone<br/>+ vancomycin"]:::action C -->|"Negative"| E{"CSF pattern?<br/>Lymphocytic,<br/>normal/low glucose?"}:::decision E -->|"Yes"| F["Viral meningitis<br/>PCR for enterovirus,<br/>HSV, VZV"]:::action F --> G{"PCR result?"}:::decision G -->|"Enterovirus<br/>positive"| H["Discontinue antibiotics<br/>& acyclovir<br/>Supportive care only"]:::action G -->|"HSV/VZV<br/>positive"| I["Continue acyclovir<br/>10 mg/kg IV 8-hourly"]:::action G -->|"All negative"| J["Likely viral<br/>Supportive care"]:::action ``` ## Why NOT the Other Options - **Option 0** — Continuing ceftriaxone and vancomycin after bacterial culture is negative and enteroviral meningitis is confirmed is unnecessary, increases antibiotic resistance, and does not improve outcomes. - **Option 1** — Acyclovir is indicated for HSV and VZV meningitis, NOT for enteroviral meningitis. Enteroviral meningitis is self-limited and does not respond to acyclovir. PCR is positive for enterovirus, not HSV. - **Option 3** — Continuing antibiotics and acyclovir, and adding immunoglobulin, is excessive and not indicated for enteroviral meningitis. Immunoglobulin is not standard therapy for enteroviral meningitis in immunocompetent hosts.